Thermo Fisher Scientific has launched a newly expanded Direct-to-Patient service offering to support decentralized clinical trials that aims to minimize clinical trial length and costs and maximize patient enrollment and participation rates. The offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable clinical trial medication delivery directly to patients’ homes. Thermo’s expanded Direct-to-Patient services build on its global C...